Publication:
Safety and efficacy of REP 2139-Mg in hepatitis D patients with advanced liver disease: an international compassionate use program

Simple item page
dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorYurdaydın, Cihan
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2025-03-06T20:59:08Z
dc.date.issued2024
dc.description.indexedbyWOS
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.identifier.eissn1600-0641
dc.identifier.issn0168-8278
dc.identifier.quartileQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14288/27639
dc.identifier.volume80
dc.identifier.wos1278309400053
dc.keywordsSafety
dc.keywordsEfficacy
dc.keywordsREP 2139-Mg
dc.keywordsHepatitis D
dc.keywordsAdvanced liver disease
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofJournal of Hepatology
dc.subjectGastroenterology and hepatology
dc.titleSafety and efficacy of REP 2139-Mg in hepatitis D patients with advanced liver disease: an international compassionate use program
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.kuauthorYurdaydın, Cihan
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit1KUH (KOÇ UNIVERSITY HOSPITAL)
local.publication.orgunit2KUH (Koç University Hospital)
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files

Collections

Publications without Fulltext